Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
“The reported incidence of bortezomib-induced peripheral neuropathy (BIPN) ranges from 25 to 75 % (among MM patients). This marks the fifteenth time I’ve written about chemotherapy/bortezomib-induced
Continue reading“…Darzalex in combination with Revlimid,Velcade and dexamethasone, (VRd), demonstrated a higher percentage of stringent complete response (sCR) among transplant eligible, newly diagnosed
Continue readingHerein, we also found that the C-B-D and T-H-C combination is able to reduce expression of the β5i subunit as well as to act in synergy with Carfilzomib to increase Myeloma cell death and inhibits cell
Continue reading“… your choices change depending on where you are in your (MM) disease state and what is it that has impacted you (side-effects) along your journey with the disease.” I know side-effects
Continue reading“…including 50 human studies involving 8,521 patients, 5,081 of whom were given nutrients, have consistently shown…” In all my experience as a multiple myeloma survivor and MM cancer
Continue readingComparing research for multiple myeloma (MM) therapies is frustrating at best, dangerous at worst. The goal for any/all MM patients is to compare one chemotherapy regimen to another in a sort of apples
Continue readingThese results showed that Cannabinoids (CBD) by itself or in synergy (integrative) with BORT strongly inhibited growth, arrested cell cycle progression and induced Multiple Myeloma cell death… Dear
Continue reading“In the multiple myeloma setting, patients tend to be older and with more comorbidities, which often prevents them from enrolling in a trial. Therefore, myeloma clinical trials are incomplete. According
Continue reading“This issue of adverse effects in (MM) survivors goes beyond peripheral neuropathy. There are other effects that need to be considered while patients are making treatment decisions.” I am a
Continue reading“Peripheral neuropathy is a common and important nonhematologic, dose-limiting adverse effect (for MM) of bortezomib-based chemotherapy…” From ’94-’97 I underwent chemotherapy
Continue reading“…there exists no evidence to suggest that early intervention in Soldering Multiple Myeloma, even when limited to patients at highest risk of progression to active MM, leads to improved overall
Continue reading“Elderly multiple myeloma patients who underwent autologous stem cell transplants showed comparable benefits, which highlights the fact that chronological age alone should not be used to determine transplantation
Continue reading